ghk-cu injection timing How Often to Inject GHK-Cu vs NAD+: Which Is
Description
Options may be supported by Grade A (high certainty), B (moderate certainty), or C (low certainty) evidence
We provide evidence that late-life (23.5 mo.) initiated intermittent MOTS-c treatment (3x/week) can increase physical capacity and healthspan in mice

L., Kawachi, I., Stampfer, M

Lu, H., Shang, P
